Summary

India Omega-3 Market Research Report Information by Type (Alpha-linolenic acid, Eicosatetraenoic Acid, and Docosahexaenoic Acid), Source (Fish, Nuts and Seeds and Plant Oils), Age Group (Paediatric, children, Sub-adults, Adults, Old), Application (Food & Beverages, Pharmaceuticals, Cosmetics, Pet Food, and Others), Form (Powder, Liquid, Gel and Capsule), Gender (Male and Females), Ens User (Residential and Commercial) Forecast to 2032
Market Overview
The India Omega-3 Market is expected to grow at a substantial CAGR of 7.23% during the review period. Omega-3 fatty acids are necessary lipids in three forms: ALA (alpha-linolenic acid), DHA (docosahexaenoic acid), and EPA (eicosapentaenoic acid). Plants supply the majority of ALA, whereas animal diets and algae carry the majority of DHA and EPA. Getting enough of each type may help to keep the retinas, brain, and other organs operating normally. Fish oil, fatty fish, flaxseed oil, and walnuts are excellent natural sources of omega-3.
The omega-3 market is differentiated by the existence of a large number of local firms selling omega-3 products that are rapidly evolving. Furthermore, rising R&D efforts and increased modernity in new goods, as well as rising diabetes prevalence, are boosting the growth of the omega-3 market throughout the forecast period.

Market Segmentation
The omega-3 market in India is divided into three types: alpha-linolenic acid, eicosatetraenoic acid, and docosahexaenoic acid. The Docosaphexaenoic Acid segment dominated the market in 2023, while the Alpha-Linolenic Acid sector is expected to grow the fastest over the forecast period (2024-2032).
According to the source, the India omega-3 Market is divided into three categories: fish, nuts & seeds, and plant oils. The Fish category dominated the market in 2023, while the Plant Oils sector is expected to grow the fastest over the forecast period (2024-2032).
The market is divided into two segments based on gender: males and females. The female sector dominated the market, while the male segment grew the fastest over the projection period.
The market is divided into five age groups: paediatrics, children, sub-adults, adults, and the elderly.
The India omega-3 Market is divided into applications such as food and drinks, pharmaceuticals, cosmetics, pet food, and others.
The Market is divided into four segments based on form: powder, liquid, gel, and capsule.
The India omega-3 Market is divided into two segments based on end users: residential and commercial.
The India omega-3 Market is divided into two segments depending on distribution channel: store-based and non-store-based.
The omega-3 market in India is divided into four regions: north, east, west, and south.

Major Players
The market's major companies are Amway India Enterprises Pvt. Ltd., Nestlé, Reckitt Benckiser Group Plc, Cipla, BASF SE, Lupin Pharmceuticals, Inc., Croda International Plc, and DSM.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 18
2.1 DEFINITION 18
2.2 SCOPE OF THE STUDY 18
2.3 RESEARCH OBJECTIVE 18
2.4 MARKET STRUCTURE 18
3 RESEARCH METHODOLOGY 19
3.1 OVERVIEW 19
3.2 DATA FLOW 21
3.2.1 DATA MINING PROCESS 21
3.3 PURCHASED DATABASE: 22
3.4 SECONDARY SOURCES: 23
3.4.1 SECONDARY RESEARCH DATA FLOW: 24
3.5 PRIMARY RESEARCH: 25
3.5.1 PRIMARY RESEARCH DATA FLOW: 26
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 27
3.6.1 REVENUE ANALYSIS APPROACH 27
3.7 DATA FORECASTING 28
3.7.1 DATA FORECASTING TYPE 28
3.8 DATA MODELING 29
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 29
3.8.2 DATA MODELING: 30
3.9 TEAMS AND ANALYST CONTRIBUTION 32
4 MARKET DYNAMICS 34
4.1 INTRODUCTION 34
4.2 DRIVERS 35
4.2.1 RISING DISPOSABLE INCOME OF INDIAN POPULATION 35
4.2.2 INCREASING CHRONIC HEALTH CONDITIONS AMONG INDIANS 35
4.3 CHALLENGES 36
4.3.1 INDIA TRADE BARRIERS AND REGULATIONS 36
4.4 RESTRAINTS 36
4.4.1 HIGH COST ASSOCIATED WITH THE INDIA OMEGA – 3 MANUFACTURING 36
4.5 OPPORTUNITY 38
4.5.1 EXPANSION OF ONLINE RETAIL AND E-COMMERCE PLATFORMS 38
5 MARKET FACTOR ANALYSIS 39
5.1 PORTER'S FIVE FORCES MODEL 39
5.1.1 THREAT OF NEW ENTRANTS 39
5.1.2 BARGAINING POWER OF SUPPLIERS 40
5.1.3 THREAT OF SUBSTITUTES 40
5.1.4 BARGAINING POWER OF BUYERS 40
5.1.5 INTENSITY OF RIVALRY 40
5.2 PRODUCT INNOVATION 40
5.2.1 NEW PRODUCT CONCEPTS 40
5.2.2 RESEARCH & DEVELOPMENT (R&D) INVESTMENT 40
5.2.3 TARGETED SOLUTIONS 41
5.2.4 CONVENIENCE & PERSONALIZATION 41
5.2.5 MICRONUTRIENT COMBINATIONS 41
5.2.6 TRANSPARENCY & TRACEABILITY 41
5.3 TECHNOLOGICAL INNOVATION 41
5.3.1 ARTIFICIAL INTELLIGENCE (AI)-POWERED MANUFACTURING 41
5.3.2 DIGITAL THERAPEUTICS 41
5.3.3 NOVEL DELIVERY SYSTEMS 42
5.3.4 BIOTECHNOLOGICAL ADVANCEMENTS 42
5.3.5 PRECISION FERMENTATION 42
6 INDIA OMEGA-3 MARKET, BY TYPE 44
6.1 OVERVIEW 44
7 INDIA OMEGA-3 MARKET, BY SOURCE 46
7.1 OVERVIEW 46
8 INDIA OMEGA-3 MARKET, BY GENDER 49
8.1 OVERVIEW 49
9 INDIA OMEGA-3 MARKET, BY AGE GROUP 51
9.1 OVERVIEW 51
10 INDIA OMEGA-3 MARKET, BY APPLICATION 53
10.1 OVERVIEW 53
11 INDIA OMEGA-3 MARKET, BY FORM 57
11.1 OVERVIEW 57
12 INDIA OMEGA-3 MARKET, BY END USER 60
12.1 OVERVIEW 60
13 INDIA OMEGA-3 MARKET, BY DISTRIBUTION CHANNEL 62
13.1 OVERVIEW 62
14 INDIA OMEGA-3 MARKET, BY REGION 64
14.1 OVERVIEW 64
14.2 NORTH 66
14.3 SOUTH 70
14.4 WEST 73
14.5 EAST 77
15 COMPETITIVE LANDSCAPE 82
15.1 INTRODUCTION 82
15.2 MARKET SHARE ANALYSIS, 2023 82
15.3 COMPETITOR DASHBOARD 83
15.4 PUBLIC PLAYERS STOCK SUMMARY 83
15.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 84
16 COMPANY PROFILES 85
16.1 AMWAY INDIA ENTERPRISES PVT. LTD. 85
16.1.1 COMPANY OVERVIEW 85
16.1.2 FINANCIAL OVERVIEW 86
16.1.3 PRODUCTS OFFERED 86
16.1.4 KEY DEVELOPMENTS 86
16.1.5 KEY STRATEGIES 86
16.2 NESTLÉ 87
16.2.1 COMPANY OVERVIEW 87
16.2.2 FINANCIAL OVERVIEW 88
16.2.3 PRODUCTS OFFERED 88
16.2.4 SWOT ANALYSIS 89
16.2.5 KEY DEVELOPMENTS 89
16.2.6 KEY STRATEGIES 89
16.3 RECKITT BENCKISER GROUP PLC 90
16.3.1 COMPANY OVERVIEW 90
16.3.2 FINANCIAL OVERVIEW 91
16.3.3 PRODUCTS OFFERED 91
16.3.4 KEY DEVELOPMENTS 92
16.3.5 SWOT ANALYSIS 92
16.3.6 KEY STRATEGIES 92
16.4 CIPLA 93
16.4.1 COMPANY OVERVIEW 93
16.4.2 FINANCIAL OVERVIEW 95
16.4.3 PRODUCTS OFFERED 95
16.4.4 SWOT ANALYSIS 96
16.4.5 KEY DEVELOPMENTS 96
16.4.6 KEY STRATEGIES 96
16.5 BASF SE 97
16.5.1 COMPANY OVERVIEW 97
16.5.2 FINANCIAL OVERVIEW 98
16.5.3 PRODUCTS OFFERED 98
16.5.4 KEY DEVELOPMENTS 99
16.5.5 KEY STRATEGIES 99
16.6 LUPIN PHARMACEUTICALS, INC. 100
16.6.1 COMPANY OVERVIEW 100
16.6.2 FINANCIAL OVERVIEW 101
16.6.3 PRODUCTS OFFERED 101
16.6.4 KEY DEVELOPMENTS 101
16.6.5 SWOT ANALYSIS 102
16.6.6 KEY STRATEGIES 102
16.7 CRODA INTERNATIONAL PLC. 103
16.7.1 COMPANY OVERVIEW 103
16.7.2 FINANCIAL OVERVIEW 104
16.7.3 PRODUCTS OFFERED 104
16.7.4 KEY DEVELOPMENTS 105
16.7.5 THERE HAVE BEEN NO RECENT DEVELOPMENTS BY THE COMPANY IN THE INDIA OMEGA-3 MARKET FOR THE PAST THREE YEARS.   105
16.7.6 SWOT ANALYSIS 105
16.7.7 KEY STRATEGIES 106
16.8 DSM 107
16.8.1 COMPANY OVERVIEW 107
16.8.2 FINANCIAL OVERVIEW 108
16.8.3 PRODUCT OFFERED 108
16.8.4 KEY DEVELOPMENTS 109
16.8.5 KEY STRATEGIES 109
16.9 UNITED LABORATORIES 110
16.9.1 COMPANY OVERVIEW 110
16.9.2 FINANCIAL OVERVIEW 110
16.9.3 PRODUCTS OFFERED 110
16.9.4 KEY DEVELOPMENTS 110
16.9.5 KEY STRATEGIES 111
16.10 LIFEVISION HEALTHCARE 112
16.10.1 COMPANY OVERVIEW 112
16.10.2 FINANCIAL OVERVIEW 112
16.10.3 PRODUCTS OFFERED 112
16.10.4 KEY DEVELOPMENTS 113
16.10.5 KEY STRATEGIES 113
17 DATA CITATIONS 114